Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q4 FY2016
As of Dec 31, 2016
Q3 FY2016
As of Sep 30, 2016
Q2 FY2016
As of Jun 30, 2016
Q1 FY2016
As of Mar 31, 2016
Q4 FY2015
As of Dec 31, 2015
Q3 FY2015
As of Sep 30, 2015
Q2 FY2015
As of Jun 30, 2015
Q1 FY2015
As of Mar 31, 2015
Q4 FY2014
As of Dec 31, 2014
Q3 FY2014
As of Sep 30, 2014
Q2 FY2014
As of Jun 30, 2014
Q1 FY2014
As of Mar 31, 2014
Q4 FY2013
As of Dec 31, 2013
Q3 FY2013
As of Sep 30, 2013
Q2 FY2013
As of Jun 30, 2013
Q1 FY2013
As of Mar 31, 2013
Q4 FY2012
As of Dec 31, 2012
Q3 FY2012
As of Sep 30, 2012
Q2 FY2012
As of Jun 30, 2012
Q1 FY2012
As of Mar 31, 2012
Assets
Current assets:
Cash and cash equivalents
Receivables:
Trade, net
Refundable income taxes
Other
Total receivables
Inventories
Work-in-process on medical interiors and products contracts
Assets held for sale
Costs and estimated earnings in excess of billings on uncompleted contracts
Refundable deposits
Prepaid expenses and other current assets
Total current assets
Property and equipment:
Land
Flight and ground support equipment
Aircraft under capital leases
Aircraft rotable spare parts
Buildings and office equipment
Property and equipment, gross
Less accumulated depreciation and amortization
Net property and equipment
Goodwill
Intangible assets, net of accumulated amortization of $41,267 and $28,093 at December 31, 2016 and 2015, respectively
Other assets
Total assets
Liabilities and Stockholders' Equity
Current liabilities:
Notes payable
Current installments of long-term debt
Current installments of obligations under capital leases
Accounts payable
Deferred revenue
Billings in excess of costs and estimated earnings on uncompleted contracts
Accrued wages and compensated absences
Due to third party payers
Deferred income taxes
Other accrued liabilities
Total current liabilities
Long-term debt, less current installments
Obligations under capital leases, less current installments
Deferred income taxes
Other liabilities
Total liabilities
Redeemable non-controlling interests
Stockholders' equity:
Common stock, $.06 par value. Authorized 70,500,000 shares; issued 39,574,788 and 39,511,350 shares at December 31, 2016 and 2015, respectively; outstanding 36,401,495 and 39,003,026 shares at December 31, 2016 and 2015, respectively
Additional paid-in capital
Treasury stock at cost, 3,053,248 and 320,988 shares at December 31, 2016 and 2015, respectively
Retained earnings
Accumulated other comprehensive loss
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support